References
- 1Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159): 1736–88. DOI: 10.1016/S0140-6736(18)32203-7
- 2World Health Organization. Noncommunicable diseases and their risk factors.
http://www.who.int/ncds/introduction/en/ (accessed 17 May 2017). - 3World Health Organization. 10 facts on noncommunicable diseases.
http://www.who.int/features/factfiles/noncommunicable_diseases/en/ (accessed 17 May 2017). - 4WHO. Third UN High-level Meeting on Non-communicable Diseases. 2018.
- 5Kundu MK, Hazra S, Pal D, Bhattacharya M. A review on noncommunicable diseases (NCDs) burden, its socio-economic impact and the strategies for prevention and control of NCDs in India. Indian J Public Health. 2018 Oct 1; 62(4): 302–4. DOI: 10.4103/ijph.IJPH_324_16
- 6Sum G, Hone T, Atun R, Millett C, Suhrcke M, Mahal A, et al. Multimorbidity and out-of-pocket expenditure on medicines: A systematic review. Vol. 3. BMJ Global Health. 2018 Feb 6; 3(1):
e000505 . DOI: 10.1136/bmjgh-2017-000505 - 7World Health Organization. Noncommunicable Diseases Progress Monitor; 2017.
- 8Patel S, Ram U, Ram F, Patel SK. Socioeconomic and demographic predictors of high blood pressure, diabetes, asthma and heart disease among adults engaged in various occupations: evidence from India. J Biosoc Sci. 2019 Oct 24; 1–21. DOI: 10.1017/S0021932019000671
- 9Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N, Foster C, et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: A systematic review. Lancet Glob Heal. 2017 Mar 1; 5(3): e277–89. DOI: 10.1016/S2214-109X(17)30058-X
- 10Laires PA, Perelman J. The current and projected burden of multimorbidity: A cross-sectional study in a Southern Europe population. Eur J Ageing. 2019 Jun 15; 16(2): 181–92. DOI: 10.1007/s10433-018-0485-0
- 11Niessen LW, Mohan D, Akuoku JK, Mirelman AJ, Ahmed S, Koehlmoos TP, et al. Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda. Vol. 391. The Lancet. 2018 May 19; 391(10134): 2036–2046. DOI: 10.1016/S0140-6736(18)30482-3
- 12Camacho PA, Gomez-Arbelaez D, Molina DI, Sanchez G, Arcos E, Narvaez C, et al. Social disparities explain differences in hypertension prevalence, detection and control in Colombia. J Hypertens. 2016: 34(12): 2344–52. DOI: 10.1097/HJH.0000000000001115
- 13Camacho PA, Otero J, Pérez M, Arcos E, García H, Narvaez C, et al. The spectrum of the dyslipidemia in Colombia: The PURE study. Int J Cardiol. 2018; pii: S0167–5273(18)33673-8.
- 14García-Olmos L, Salvador CH, Alberquilla Á, Lora D, Carmona M, García-Sagredo P, et al. Comorbidity patterns in patients with chronic diseases in general practice. PLoS One. 2012; 7(2): e32141. DOI: 10.1371/journal.pone.0032141
- 15Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): A prospective cohort study. Lancet. 2019 Sep 3; pii: S0140–6736(19)32007-0.
- 16Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular risk and events in 17 low-, medium-, and high incomes countries. N Engl J Med. 2014; 371: 818–827. DOI: 10.1056/NEJMoa1311890
- 17Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. Lancet. 2019; 6736(19): 1–14. DOI: 10.1016/S0140-6736(19)32008-2
- 18Rafique I, Saqib MAN, Munir MA, Qureshi H, Rizwanullah, Khan SA, et al. Prevalence of risk factors for noncommunicable diseases in adults: Key findings from the Pakistan STEPS survey. East Mediterr Health J. 2018 Apr 5; 24(1): 33–41. DOI: 10.26719/2018.24.1.33
- 19McNamara CL, Balaj M, Thomson KH, Eikemo TA, Solheim EF, Bambra C. The socioeconomic distribution of non-communicable diseases in Europe: Findings from the European Social Survey (2014) special module on the social determinants of health. Eur J Public Health. 2017 Feb; 27(suppl_1): 22–6. DOI: 10.1093/eurpub/ckw222
- 20Katikireddi SV, Skivington K, Leyland AH, Hunt K, Mercer SW. The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: A longitudinal analysis of the Twenty-07 cohort. BMC Med. 2017; 15(1): 152. DOI: 10.1186/s12916-017-0913-6
- 21Kien VD, Van Minh H, Giang KB, Dao A, Weinehall L, Eriksson M, et al. Socioeconomic inequalities in self-reported chronic non-communicable diseases in urban Hanoi, Vietnam. Glob Public Health. 2017 Dec 2; 12(12): 1522–37. DOI: 10.1080/17441692.2015.1123282
- 22Rosbach M, Andersen JS. Patient-experienced burden of treatment in patients with multimorbidity–A systematic review of qualitative data. van Wouwe JP (ed.), PLoS One. 2017 Jun 23; 12(6):
e0179916 . DOI: 10.1371/journal.pone.0179916 - 23Arokiasamy P, Uttamacharya, Kowal P, Capistrant BD, Gildner TE, Thiele E, et al. Chronic noncommunicable diseases in 6 low- and middle-income countries: Findings from wave 1 of the world health organization’s Study on Global Ageing and Adult Health (SAGE). Vol. 185. American Journal of Epidemiology. 2017 Mar 15; 185(6): 414–428. DOI: 10.1093/aje/kww125
- 24Stanojević Jerković O, Sauliūnė S, Šumskas L, Birt C, Kersnik J. Determinants of self-rated health in elderly populations in urban areas in Slovenia, Lithuania and UK: Findings of the EURO-URHIS 2 survey. Eur J Public Health. 2017 May 1; 27(suppl_2): 74–79.
- 25Liu Y, Liu G, Wu H, Jian W, Wild SH, Gasevic D. Sex differences in non-communicable disease prevalence in China: A cross-sectional analysis of the China Health and Retirement Longitudinal Study in 2011. BMJ Open. 2017 Dec 14; 7(12):
e017450 . DOI: 10.1136/bmjopen-2017-017450 - 26Smith DRM, Dolk FCK, Smieszek T, Robotham JV, Pouwels KB. Understanding the gender gap in antibiotic prescribing: A cross-sectional analysis of English primary care. BMJ Open. 2018 Feb 22; 8(2):
e020203 . DOI: 10.1136/bmjopen-2017-020203 - 27Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet. 2016; 387: 61–69. DOI: 10.1016/S0140-6736(15)00469-9
- 28Avezum A, Oliveira GB, Lanas F, Lopez-Jaramillo P, Diaz R, Miranda JJ, et al. Secondary CV prevention in South America in a community setting: The PURE study. Glob Heart. 2017; 12: 305–313. DOI: 10.1016/j.gheart.2016.06.001
- 29Corsi DJ, Subramanian SV, Chow CK, McKee M, Chifamba J, Dagenais G, et al. Prospective urban rural epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J. 2013 Oct 1; 166(4). DOI: 10.1016/j.ahj.2013.04.019
- 30DANE. Boletín Técnico Pobreza Multidimensional en Colombia Pobreza multidimensional en Colombia. 2018.
https://www.dane.gov.co/files/investigaciones/condiciones_vida/pobreza/2018/bt_pobreza_multidimensional_18.pdf (accessed 28 Nov 2019).
